Clinical trial
A Multicenter, Randomized, Double-Blind, Sham-Controlled, Pivotal Clinical Investigation to Evaluate the Efficacy and Safety of the Digital Therapeutic 'BELL-001' for Improving Symptoms in Patients With Insomnia
NCT07295431 is registered in ClinicalTrials.gov with BELL Therapeutics Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-Blind, Sham-Controlled, Pivotal Clinical Investigation to Evaluate the Efficacy and Safety of the Digital Therapeutic 'BELL-001' for Improving Symptoms in Patients With Insomnia
- Lead sponsor
- BELL Therapeutics Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 4, 2026
- Completion date
- July 24, 2026
- Enrollment
- 116 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.